Butane

Butane

SCHEMBL22813

CCCC.CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL17460145 1.00 TSHR (0.44)
Butane SCHEMBL9400770 0.94
Butane SCHEMBL8078516 0.94
Butane SCHEMBL7082330 0.88 TSHR (0.36)
Butane SCHEMBL6336632 0.88
Butane SCHEMBL4594497 0.86 TSHR (0.44)
Butane SCHEMBL7258069 0.86
Butane SCHEMBL2140500 0.86 TSHR (0.44)
Butane SCHEMBL9292387 0.84 TSHR (0.50)
Butane SCHEMBL1734106 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 522 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289729-A1 BICONICAL TUNGSTEN (MOLYBDENUM) TRIOXIDE POWDER, AND PREPARATION METHOD AND USE THEREOF ZHENGZHOU UNIVERSITY OF LIGHT INDUSTRY (CN) 2025-09-18 US claimed
US-12288909-B2 Method for manufacturing membrane-electrode assembly using nano-dispersed ionomer binder, and membrane-electrode assembly manufactured thereby DANKOOK UNIVERSITY CHEONAN CAMPUS INDUSTRY ACADEMIC COOPERATION FOUNDATION (KR) 2025-04-29 US claimed
EP-3688773-B1 SILVER-CONTAINING NON-AQUEOUS COMPOSITION CONTAINING CELLULOSIC POLYMERS EASTMAN KODAK CO (US) 2025-02-19 EP claimed
US-20240162465-A1 METHOD FOR MANUFACTURING MEMBRANE-ELECTRODE ASSEMBLY USING NANO-DISPERSED IONOMER BINDER, AND MEMBRANE-ELECTRODE ASSEMBLY MANUFACTURED THEREBY DANKOOK UNIVERSITY CHEONAN CAMPUS INDUSTRY ACADEMIC COOPERATION FOUNDATION (KR) 2024-05-16 US claimed
CN-118026266-A Biconical tungsten (molybdenum) trioxide powder, and preparation method and application thereof 郑州轻工业大学 2024-05-14 CN claimed
EP-4328358-A1 METHOD FOR MANUFACTURING MEMBRANE-ELECTRODE ASSEMBLY USING NANO-DISPERSED IONOMER BINDER, AND MEMBRANE-ELECTRODE ASSEMBLY MANUFACTURED THEREBY Dankook University Cheonan Campus Industry Academic Corporation Foundation (KR) 2024-02-28 EP claimed
CN-111163879-B Method for producing silver-containing dispersions with nitrogen-containing bases 伊斯曼柯达公司 2022-05-06 CN claimed
US-10851257-B2 Silver and copper nanoparticle composites EASTMAN KODAK COMPANY (US) 2020-12-01 US claimed
EP-3687716-A1 METHOD OF MAKING SILVER-CONTAINING DISPERSIONS WITH NITROGENOUS BASES Eastman Kodak Company (US) 2020-08-05 EP claimed
EP-3688773-A1 SILVER-CONTAINING NON-AQUEOUS COMPOSITION CONTAINING CELLULOSIC POLYMERS Eastman Kodak Company (US) 2020-08-05 EP claimed
WO-2004092165-A1 3-BENZHYDRYLIDENE-8-AZA-BICYCLO[3.2.1]OCTANE DERIVATIVES WITH OPIOID RECEPTOR ACTIVITY PFIZER PRODUCTS INC. (US) 2004-10-28 WO claimed
US-20040138220-A1 4,4-Biarylpiperidine derivatives PFIZER, INC. 2004-07-15 US claimed
US-6720336-B2 USED AS LIGANDS FOR OPIOID RECEPTORS, FOR THERAPY OF NEUROLOGICAL AND GASTROINTESTINAL DISORDERS PFIZER, INC. 2004-04-13 US claimed
US-20020077323-A1 Use of delta opioid receptor ligands and serotonin reuptake inhibitors in the treatment of chemical dependencies PFIZER INC. 2002-06-20 US claimed
US-20020013321-A1 4,4-Biarylpiperidine derivatives PFIZER INC. 2002-01-31 US claimed
CN-1316993-A 4,4-biarylpiperidime derivatives with opioid receptor activity PFIZER PROD INC (US) 2001-10-10 CN claimed
EP-1112255-A1 4,4-BIARYLPIPERIDINE DERIVATIVES WITH OPIOID RECEPTOR ACTIVITY Pfizer Products Inc. (US) 2001-07-04 EP claimed
WO-2000014066-A1 4,4-BIARYLPIPERIDINE DERIVATIVES WITH OPIOID RECEPTOR ACTIVITY PFIZER PRODUCTS INC. (US) 2000-03-16 WO claimed
EP-0210886-B1 TERTIARY HALOGENATED BIPHENYL ALCOHOLS THERAPEUTICALLY USEFUL IN THE TREATMENT OF ATHERIOSCLEROSIS PIERRE FABRE MEDICAMENT (FR) 1988-08-24 EP claimed
EP-0210886-A1 Tertiary halogenated biphenyl alcohols therapeutically useful in the treatment of atheriosclerosis PIERRE FABRE MEDICAMENT (FR) 1987-02-04 EP claimed